Abstract
Twenty patients with Vogt-Koyanagi-Harada disease who had been given systemic corticosteroids were retrospectively analyzed. Sixteen patients were successfully treated with systemic corticosteroids without recurrence of uveitis. Since the advent of corticosteroid treatment, there have been fewer ocular complications as well as extraocular signs and symptoms in most cases. Recurrence of the inflammation, however, occurred in four cases. Drip infusion of 200 mg prednisolone daily, widely employed for the treatment, did not always have good results. It is suggested that the dosage of corticosteroid should be adjusted according to the severity of uveomeningitis. Oral administration of corticosteroid (less than 100 mg prednisolone daily) may be enough for suppression of the inflammation in the Harada type, while a drip infusion of the massive dosage (more than 200 mg prednisolone daily) with gradual tapering off is possibly requisite in the Vogt-Koyanagi type.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Deutman AF, Oosterhuis JA, Boen-tan TN, Aan De Kerk AL (1972) Acute posterior multifocal placoid pigment epitheliopathy. Pigment eptheliopathy or choriocapillaritis. Br J Ophthalmol 56:863–874
Fastenberg DM, Fetkenhour CL, Choromokos E, Shoch DE (1980) Choroidal vascular changes in toxemia of pregnancy. Am J Ophthalmol 89:362–368
Gass JDM (1973) Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol 75:810–821
Hamilton AM, Bird AC (1974) Geographical choroidopathy. Br J Ophthalmol 58: 784–797
Izawa Y (1978) On the diagnostic criteria for Harada disease. Jpn Rev Clin Ophthalmol 72: 1464
Kawata K, Oka Y (1977) The Vogt-Koyanagi-Harada syndrome. A 14-year review. Jpn J Clin Ophthalmol 31:17–22
Masuda K, Tanishima T (1969) Harada's disease. A new therapeutic approach. Jpn J Clin Ophthalmol 23:553–555
Mimura Y (1978) Diagnostic criteria for Harada disease. Jpn Rev Clin Ophthalmol 72: 1463–1464
Ohno S, Char DH, Kimura SJ, O'Connor GR (1977) Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 83:735–740
Perry HD, Font RL (1977) Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 83:242–254
Satoh Y (1978) Harada's disease and corticosteroid therapy. Folia Ophthalmol Jpn 29: 1494–1496
Schepens CL, Brockhurst RJ (1963) Uveal effusion, i. Clinical picture. Arch Ophthalmol 70:189–201
Shimizu K (1973) Harada's, Behcet's Vogt-Koyanagi syndromes are they clinical entities? Trans Am Acad Ophthalmol Otolaryngol 77:281–290
Snyder DA, Tessler HH (1980) Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 90:69–75
Sugiura S (1978) Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 22:9–35
Tsukahara I, Uyama M (1978) Central serous choroidopathy with bullous retinal detachment. Albrecht Von Graefes Arch Klin Exp Ophthalmol 206:169–178
Urayama A (1970) Choroid. In: Ohtsuka J, Shikano S (ed) “Rinsho Ganka Zensho”. Kanahara Pub Co, Tokyo, Vol 4, pp 75–158
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayasaka, S., Okabe, H. & Takahashi, J. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefe's Arch Clin Exp Ophthalmol 218, 9–13 (1982). https://doi.org/10.1007/BF02134092
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02134092